Vifor Fresenius Medical Care Renal Pharma
Quick facts
Phase 3 pipeline
- Difelikefalin Injection · Nephrology
Difelikefalin is a selective agonist of the peripheral kinin B1 receptor that reduces pruritus by modulating inflammatory pathways in patients with chronic kidney disease.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Vifor Fresenius Medical Care Renal Pharma portfolio CI brief
- Vifor Fresenius Medical Care Renal Pharma pipeline updates RSS
Frequently asked questions about Vifor Fresenius Medical Care Renal Pharma
What is Vifor Fresenius Medical Care Renal Pharma's pipeline?
Vifor Fresenius Medical Care Renal Pharma has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Difelikefalin Injection.
Related
- Sector hub: All tracked pharma companies